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The Hop-Like Stress-Induced Protein 1 Cochaperone Is a Novel
Cell-Intrinsic Restriction Factor for Mitochondrial Tombusvirus
Replication
Kai Xu,a Jing-Yi Lin,a,b Peter D. Nagya
Department of Plant Pathology, University of Kentucky, Lexington, Kentucky, USAa; School of Medical Laboratory Science and Biotechnology, College of Medical Science
and Technology, Taipei Medical University, Taiwanb
ABSTRACT
Recent genome-wide screens reveal that the host cells express an arsenal of proteins that inhibit replication of plus-stranded
RNA viruses by functioning as cell-intrinsic restriction factors of viral infections. One group of cell-intrinsic restriction factors
against tombusviruses contains tetratricopeptide repeat (TPR) domains that directly interact with the viral replication proteins.
In this paper, we find that the TPR domain-containing Hop-like stress-inducible protein 1 (Sti1p) cochaperone selectively inhib-
its the mitochondrial membrane-based replication of Carnation Italian ringspot tombusvirus (CIRV). In contrast, Sti1/Hop
does not inhibit the peroxisome membrane-based replication of the closely related Tomato bushy stunt virus (TBSV) or Cucum-
ber necrosis virus (CNV) in a yeast model or in plants. Deletion of STI1 in yeast leads to up to a 4-fold increase in CIRV replica-
tion, and knockdown of the orthologous Hop cochaperone in plants results in a 3-fold increase in CIRV accumulation. Overex-
pression of Sti1p derivatives in yeast reveals that the inhibitory function depends on the TPR1 domain known to interact with
heat shock protein 70 (Hsp70), but not on the TPR2 domain interacting with Hsp90. In vitro CIRV replication studies based on
isolated mitochondrial preparations and purified recombinant proteins has confirmed that Sti1p, similar to the TPR-containing
Cyp40-like Cpr7p cyclophilin and the Ttc4 oncogene-like Cns1 cochaperone, is a strong inhibitor of CIRV replication. Sti1p in-
teracts and colocalizes with the CIRV replication proteins in yeast. Our findings indicate that the TPR-containing Hop/Sti1 co-
chaperone could act as a cell-intrinsic virus restriction factor of the mitochondrial CIRV, but not against the peroxisomal tom-
busviruses in yeast and plants.
IMPORTANCE
The host cells express various cell-intrinsic restriction factors that inhibit the replication of plus-stranded RNA viruses. In this
paper, the authors find that the Hop-like stress-inducible protein 1 (Sti1p) cochaperone selectively inhibits the mitochondrial
membrane-based replication of Carnation Italian ringspot tombusvirus (CIRV) in yeast. Deletion of STI1 in yeast or knock-
down of the orthologous Hop cochaperone in plants leads to increased CIRV replication. In addition, overexpression of Sti1p
derivatives in yeast reveals that the inhibitory function depends on the TPR1 domain known to interact with heat shock protein
70 (Hsp70), but not on the TPR2 domain interacting with Hsp90. In vitro CIRV replication studies based on isolated mitochon-
drial preparations and purified recombinant proteins have confirmed that Sti1p is a strong inhibitor of CIRV replication. The
authors’ findings reveal that the Hop/Sti1 cochaperone could act as a cell-intrinsic restriction factor against the mitochondrial
CIRV, but not against the related peroxisomal tombusviruses.
Cells produce a yet-unknown number of cell-intrinsic restric-tion factors that limit replication of plus-stranded RNA
[()RNA] viruses. The cellular restriction factors could be virus
specific or components of the cell-intrinsic innate systems of the
host through targeting diverse pathogens (1–7). Cellular factors
are also recruited by ()RNA viruses to aid viral replication,
which takes place in membrane-bound viral replicase complexes
(VRCs) in the cytoplasm of infected cells (8–16). The diverse,
often opposite, roles of host factors are reflected by the identifica-
tion of stimulatory as well as inhibitory host proteins in genome-
wide screens with various hosts and viruses, such as Tomato bushy
stunt virus (TBSV), West Nile virus, Brome mosaic virus (BMV),
Hepatitis C virus (HCV), Dengue virus, and Drosophila virus C
(17–25). However, the detailed functions of the majority of the
identified host proteins in ()RNA virus replication have not
been fully revealed.
TBSV is a plant-infecting ()RNA virus used extensively to
study virus replication, recombination, and virus-host interac-
tions based on a yeast (Saccharomyces cerevisiae) model (26–29).
We have performed several genome-wide screens of yeast genes by
using different global proteomics approaches that have led to the
identification of over 500 host genes/proteins putatively involved
in TBSV replication or recombination (17, 19, 30–40). The above-
mentioned systematic screens have identified host stimulatory
and restriction factors of TBSV replication. For example, the
Cyp40-like Cpr7p cyclophilin and the Ttc4 oncogene-like Cns1p
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cochaperone are strong inhibitors of TBSV replication in yeast
and in vitro (41, 42). Additional cellular cyclophilins, such as the
CypA, and the related Ess1p parvulin also decrease TBSV RNA
accumulation in yeast and plants (36, 41, 43). Moreover, the cel-
lular nucleolin, an RNA-binding protein, inhibits TBSV replica-
tion by blocking the recruitment of the viral RNA into replication
(44). Another group of cellular restriction factors is the WWmo-
tif-containing host proteins, such as Rsp5p Nedd4-like E3 ubiq-
uitin ligase, which regulate the degradation of tombusviral p92pol
in yeast cells and inhibit the activity of VRC in vitro (45, 46).
Cellular kinases, such as Pkc1p, could also restrict TBSV replica-
tion in yeast (32). Taken altogether, studies of cellular restriction
factors could help to unravel the full arsenal of the native cell-
intrinsic innate immune system in the host cell.
Similar to other ()RNA viruses, tombusviruses, such as
TBSV, use intracellular membranes for replication. Interestingly,
TBSV utilizes the peroxisomal membrane, while the closely re-
lated Carnation Italian ringspot virus (CIRV) takes advantage of
the outer mitochondrial membranes to build VRCs in infected
plants and yeast (47–49). The two viral replication proteins (i.e.,
p33 and p92pol for TBSV and p36 and p95pol in the case of CIRV)
is known to coopt 8 to 10 host proteins to assemble the tombus-
virus VRC (37–39, 50–52). The highly homologous p33 of TBSV
and p36 of CIRV replication proteins are master regulators of
replication, playing a multifunctional role in recruitment of the
tombusviral ()RNA to the site of replication, the assembly of the
VRC, and viral RNA synthesis by acting as RNA chaperones (50,
53–57). The RdRp protein p92pol of TBSV and p95pol of CIRV are
also components of the functional VRCs (28, 55, 57–59). The
subverted host proteins have been shown to bind to the viral RNA
and the viral replication proteins (8, 39, 60). Detailed studies
showed that heat shock protein 70 (Hsp70), eukaryotic elongation
factor 1A (eEF1A), and several members of the endosomal sorting
complexes required for transport (ESCRT) family of host proteins
are required for the assembly of VRCs (52, 61–64). Additional
subverted host proteins include the DDX3-like Ded1p/AtRH20
and the human p68-like Dbp2, the eIF4AIII-like Fal1/AtRH2 and
DDX5-like Dbp3/AtRH5 DEAD-box RNA helicases, glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH), eEF1B, and eEF1A,
all ofwhichhave been shown to affect viral RNAsynthesis (51, 60, 61,
65–68).
Previous works with TBSV revealed the unexpected inhibitory
function for several tetratricopeptide repeat (TPR) domain-con-
taining proteins, such as the Cyp40-like Cpr7p cyclophilin and
Ttc4-like Cns1p cochaperone in yeast and in vitro (41, 42). Mech-
anistic studies showed that the inhibitory effect of Cpr7p was due
to its interaction with the RNA-binding domain of the tombusvi-
ral p33 replication protein that leads to inhibition of p33/p92pol-
based recruitment of the TBSV ()RNA for replication and a
decrease of the efficiency of the VRC assembly. Importantly, the
key element in Cpr7p was not the cyclophilin domain, but its TPR
domain consisting of three TPRmodules in Cpr7p (41). Similarly,
via its TPR domain, Cns1p bound to the tombusviral p33 and
p92pol replication proteins and inhibited VRC assembly and re-
duced TBSV replication in yeast and in vitro based on a yeast
cell-free extract (CFE) assay (42). However, in case of Cns1p, the
interaction targeted the p33-p33/p92 interaction domain, sug-
gesting that TPR-containing cellular proteinsmight restrict TBSV
replication via different mechanisms.
The TPR domain consists of repeats of a 34-amino-acid se-
quence adopting a right-handed helical helix-loop-helix structure
with an amphipathic channel; such channels are involved inmany
protein-protein interactions (69, 70). Although the TPR do-
mains are highly variable, which likely affects substrate speci-
ficity, the canonical TPR domain contains a pattern of small
and large hydrophobic amino acids. The TPR domain proteins
are abundant in all kingdoms of life, including 246 proteins in
Arabidopsis, 338 in mouse, 63 in Caenorhabditis elegans and 26 in
yeast (Interpro database, http://www.ebi.ac.uk/interpro/entry
/IPR013026/taxonomy) (71). TPR domain proteins function in
protein trafficking, protein import to organelles, transposon si-
lencing, apoptosis, and synaptic vesicle fusion (72, 73). Various
TPR domain proteins are involved in numerous human diseases,
such as cancer, amyloidosis, cystic fibrosis, prion protein propa-
gation, and bacterial pathogenesis (74–79). Several TPR domain
proteins have been shown to affect infections by viruses, such as
Chikungunya virus,West Nile virus,Vesicular stomatitis virus,Her-
pes simplex virus, Poxvirus, and baculoviruses (80–85). TPR do-
main proteins are also important in interferon-induced antiviral
responses, including the IFN-induced protein with tetratricopep-
tide repeats (IFIT) protein family (5, 85–88).
Our previous discoveries invited our attention to TPR-like se-
quences, including the well-studied stress-induced protein 1
(Sti1p in yeast, Hop protein in mammals and plants) cochaper-
one. Sti1p, which is a conserved highly abundant protein lacking
chaperone activity on its own, is a cochaperone of Hsp70 and
Hsp90 chaperones (89, 90). Sti1p contains three TPR domains,
which are involved in binding to Hsp90s and Hsp70s. Sti1p plays
a role in client protein transfer from the Hsp70 complex to the
Hsp90 complex. Interestingly, Sti1p can simultaneously bind to
Hsp70 andHsp90, and by inhibiting the ATPase activity ofHsp90,
Sti1p stabilizes the ternary Hsp70-Hsp90-client protein interme-
diate complex (91, 92).
In this paper, we show that the yeast Sti1p cochaperone has a
strong inhibitory function during the mitochondrial CIRV repli-
cation but not in the peroxisomal tombusvirus replication. De-
tailed analysis of Sti1p revealed that it interacted with the RNA-
binding domain of CIRV p36 replication protein and ultimately
restricted VRC assembly in vitro and CIRV RNA accumulation in
yeast and the orthologous Hop inhibited CIRV accumulation in
plants. Thus, TPR-containing cellular cochaperone proteins
emerge as new cell-intrinsic restriction factors of a mitochondrial
()RNA virus.
MATERIALS AND METHODS
Yeast strains and expression plasmids. Yeast strains BY4741 (MATa
his31 leu20 met150 ura30) and sti1 (single-gene deletion strain)
were obtained from Open Biosystems (Huntsville, AL, USA). For tom-
busviral replication in yeast, pESC-HisCNVp33-DI72, pYES-CNVp92,
pESC-C36/DI72, and pYES-C95 were described previously (57). To gen-
erate pESC-C36/DI1, CIRV DI-1 (93) (constructed by D. Barajas and
P. D. Nagy, unpublished data) was PCR amplified using primer pair 4124
(CCGGAATTCAGAAATATCTCAGGATTTGACCGTCC)/1069(CCGG
TCGAGCTCTACCAGGTAATATACCACAACGTGTGT), digested with
EcoRI/SacI, and then inserted into EcoRI/SacI-digested pESC-HisC-
NVp33-DI72, generating pESC-HisCNVp33-DI1. Cucumber necrosis vi-
rus (CNV) p33 sequencewas then removed byBamHI/XhoI digestion and
replaced with BamHI/XhoI-digested CIRV p36 sequence, which was PCR
amplified from pESC-C36/DI72 using primer pair 900 (CGACGGATCC
GAGGGTTTGAAGGCTGAGTCTACCA)/3230 (CCGCTCGAGCTATT
TGACACCGAGGGATT), generating pESC-C36/DI1.
Xu et al.
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To generate Twin-Strep-tagged CIRV and CNV replication proteins,
the primer pairs 5351 (CATCCACAATTCGAAAAATCTGCTGGTGGA
GGTGGATCCATGGATACCATCAAGAGGATG)/952 (CCCGCTCGA
GTCATGCTACGGCGGAGTCAAGGA), 5350 (GTGGTTCTGGTGGT
GGTTCTGGTGGTTCTGCTTGGTCTCATCCACAATTCGAAAAATC
TG)/952, and 5349 (GGAAGATCTAAAAATGTCTGCTTGGTCTCA
TCCACAATTCGAAAAAGGTGGTGGTTCTGGTGGTGGTTCTGGT
GG)/952 were sequentially used for PCR using template pYES-CNVp92
to introduce the Twin-Strep tag on CNV p92, generating a Twin-Strep-
tagged CNV p92 sequence. The DNA was then digested with BglII/XhoI
and inserted into pESC-DI72, generating pESC-StrepCNVp92/DI72.
CIRV p36 sequence was PCR amplified using primer pair 900/3230 and
digested with BamHI/XhoI and then inserted into BamHI/XhoI-digested
pESC-StrepCNVp92/DI72, generating pESC-StrepC36/DI72. To gener-
ate pYES-StrepC95, pYES2-NTA (Invitrogen) was digested with HindIII/
KpnI and then treated with T4 DNA polymerase and subsequently self-
ligated to remove the His6 tag. The modified pYES2-NTA vector without
theHis6 tagwas digestedwith BamHI/XhoI and usedwith the BglII/XhoI-
digested PCR product of Twin-Strep-tagged CNVp92 for ligation, gener-
ating pYES-StrepC92. CIRV p95 sequence was PCR amplified using
primer pair 900/970 (CCCGCTCGAGTCAAGCTACGGCGGAGTCGA
GGA) frompYES-C95, digestedwithBamHI/XhoI, and then inserted into
BamHI/XhoI-digested pYES-StrepC92, generating pYES-StrepC95.
To generate yeast vector expressing the STI1 gene, pTEF1 promoter
and tCYC1 terminator were PCR amplified from yeast genomic DNA and
pESC-C36/DI72 (57), respectively, using primer pair 2764 (CCGCGAGC
TCATAGCTTCAAAATGTTTCTAC)/3726 (CCGCGCGGCCGCGTAA
TTAAAACTTAGATTAGATTGC) or 3728 (CCGCGTCGACGAGGGCC
GCATCATGTAA)/3730 (CCGCGGGCCCAGCTTGCAAATTAAAGCC
TTC) and digested with SacI/NotI or ApaI/SalI. Digested pTEF1 and
tCYC1 were sequentially inserted into SacI/NotI or ApaI/SalI-digested
pRS315 vector, generating pRS315-pTEF1 (Zhenghe Li and P. D. Nagy,
unpublished data). pRS315-pTEF1 was digested with NotI/SalI and li-
gated with annealed primer pair 5157 (GGCCGAAAATGAGATCTG
GCACTAGTGACTACAAGGACGACGATGACAAGGGTGGCGG
TC)/5158 (CTAGGACCGCCACCCTTGTCATCGTCGTCCTTGTAGT
CACTAGTGCCAGATCTCATTTTC) to introduce a Flag tag, generating
pRS315-NFlag.
Plasmids expressing wild-type (wt) Sti1p or derivatives (C49Y, G325D,
TPR2, or TPR1) were generated by using available STI1 mutants (94,
95) in PCR amplifications using primer pairs 2863 (CGCGGGATCCAT
GTCATTGACAGCCGATG)/2864 (CGCGCTCGAGTTAGCGGCCAGT
CCGGATG) or 5156 (CGCGGGATCCAACCCAAAAACTAGCGAAAT
GATG)/2864, and the obtained PCR products were treated with BamHI/
SalI and then were inserted into BamHI/SalI-digested pRS315-NFlag. To
visualize Sti1p in yeast, mRFP1 was PCR amplified from pGAD-PEX13-
RFP (64) using primer pair 2630 (CGCGGGATCCATGGCCTCCTCCG
AGGACGTC)/5159 (GGACTAGTGGCGCC-GGTGGAGTGG), and the
PCR product was digested with BamHI/PstI and inserted into BglII/PstI-
digested pRS315-Sti1 to generate pRS315-mRFP1-Sti1.
Escherichia coli-based expression plasmids, pGEX-2T-Sti1 and mu-
tated derivatives (C49Y, G325D, TPR1, TPR2) were generated by PCR
using primers 2863 (CGCGGGATCCATGTCATTGACAGCCGATG)
and 4860 (CGCCGAATTCTTAGCGGCCAGTCCGGATGAT), followed
by digestion with BamHI/EcoRI and then ligation into BamHI/EcoRI-
digested pGEX-2T.
Arabidopsis thaliana STI1 ortholog AtHOP-1 (96) (AT4G12400, re-
named AtHOP3 in reference 131) and the TPR1 deletion version
(AtHOP1TPR1) were PCR-amplified from Arabidopsis cDNA using
primer pairs 5659 (CGCTGATCAATGGCGGAAGAAGCAAAATCCAA
AGG)/5661 (CCGCTCGAGTTACCGGACCTGAACAATTCCGGCACT
AACC) and 5660 (CGCTGATCAATGGATCCGGGGACTAGGGTTTAT
TTGGAG)/5661, respectively, followed by digestion with BclI/XhoI,
and the PCR products were inserted into BamHI/SalI-digested pRS315-
NFlag, generating pRS315-AtHOP1 and pRS315-AtHOP1TPR1, re-
spectively.
Analysis of CIRV repRNA replication in yeast. For measuring CIRV
replicon RNA (repRNA) accumulation, yeast strains BY4741 and sti1
were transformed with plasmids pESC-C36/DI72 and pYES-C95. For
complementation and overexpression studies, we transformed yeast
strains BY4741 and sti1 with pRS315-Sti1 (FLAG-Sti1 plasmid). Tom-
busvirus repRNA replication was induced by culturing in synthetic com-
plete medium lacking Ura, Leu, and His (sc-ULH) with 2% galactose
medium after overnight culture and then yeast was cultivated for 2 days at
23°C. Total RNA was isolated from yeast and used for detection of
repRNA levels by Northern blotting as described previously (97). Repli-
cation was calculated by measuring the accumulation of CIRV DI1
repRNA or the TBSV DI-72() repRNA relative to the accumulation of
18S rRNA.The tombusvirus replication protein analysis was performed as
described previously using an anti-His6 antibody as the primary antibody
for the detection of His6-p36 and His6-p95. Detection of Flag-Sti1p and
Sti1p was carried out using primary anti-Flag and anti-Sti1 antibody,
respectively. The secondary antibody for both primary antibodies was
alkaline phosphatase-conjugated anti-mouse immunoglobulinG (Sigma)
(41).
Analysis of protein-protein interactionby split-ubiquitin assay.The
bait constructs, pGAD-BT2-N-His36 and pGAD-BT2-N-His33, express-
ing CIRV replication protein p36 and p33 tombusvirus replication pro-
tein, have been published before (36, 38). The PCR products of the STI1
gene and its various truncation versions were digested with BamHI/XhoI
and ligated into the pPRN-N-RE vector digested with BamHI/SalI en-
zymes. The PCR products of AtHop-1 (96) was digested with BclI/XhoI
and ligated into the pPRN-N-RE vector digested with BclI/XhoI enzymes.
Yeast strain sti1/NMY51 was cotransformed with pGAD-BT2-N-His36
or pGAD-BT2-N-His33 and pPR-N-RE (NubG) or one of the prey con-
structs carrying the STI1 gene and plated onto Trp/Leu (TL) syn-
thetic minimal medium plates for plasmid selection (36, 38). Yeast colo-
nies were resuspended in 50l water and spotted onto Trp/Leu/His/
Ade (TLHA) plates for 2 to 4 days to detect bait-prey interactions.
Plasmid containing the yeast SSA1Hsp70 gene served as the positive con-
trol and an empty vector (pPR-N-RE) as the negative control in this assay
(36, 38).
Protein purification from E. coli. pMAL-p33 (TBSV p33), pMAL-
p92 (TBSV p92), pMAL-p36 (CIRV p36), and pMAL-p95 (CIRV p95)
(40) were transformed separately into E. coli strain BL21(DE3)
CodonPlus. Protein expression was induced using isopropyl -D-thioga-
lactopyranoside (IPTG) for 8 h at 16°C, and the cells were harvested by
centrifugation at 5,000 rpm at 4°C for 5 min to remove the medium
prior to 80°C storage. Affinity columns containing amylose resin
(NEB) were used to purify maltose-binding protein (MBP)-tagged
recombinant proteins. The frozen pellets were suspended and soni-
cated in MBP column buffer containing 20 mM Tris-Cl (pH 8.0), 150
mMNaCl, 1 mM EDTA, 10 mM -mercaptoethanol, and 1 mM phen-
ylmethylsulfonyl fluoride (PMSF). The sonicated extract was centri-
fuged at 15,000 rpm for 5 min, and the supernatant was added to the
preequilibrated amylose resin for a 1-h rotating incubation at 4°C.
After the resin was washed three times with column buffer and once
with a low-salt column buffer (25 mMNaCl), the proteins were eluted
with a low-salt column buffer containing 0.18% (vol/wt) maltose and
stored at80°C in 6% (vol/vol) glycerol. Protein fractions used for the
replication assays were 95% pure, as determined by 12% SDS-PAGE
and staining with Coomassie blue.
Expression of glutathione S-transferase (GST)-tagged proteins Cpr7p,
Cpr7-TPRp, Cns1p, Sti1p and their mutated versions (C49Y, G325D,
TPR1, and TPR2) were induced using IPTG for 6 h at 23°C, and the
cells were harvested by centrifugation at 5,000 rpm at 4°C for 5 min to
remove the medium and stored at 80°C. Purification of GST-tagged
proteins was carried out using glutathione resin and eluted with 10 mM
Sti1 Cochaperone Inhibits Tombusvirus Replication
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glutathione–10 mM -mercaptoethanol in the column buffer following
the same protocol as that for MBPs.
In vitro tombusvirus replication assay using yeast mitochondrial
preparations. Yeast intact mitochondria were purified as described pre-
viously (40). The purified mitochondrial fraction (1 l) and different
dilutions of GST, Sti1p, Cpr7p, or Cns1p proteins (8, 16, and 32Meach)
were incubated at 25°C for 1 h in 8l bufferA (containing 30mMHEPES-
KOH [pH 7.4], 150 mM potassium acetate, 5 mM magnesium acetate,
and 0.6 M sorbitol) with 15 mM creatine phosphate, 1 mM ATP, and
GTP, 0.1 mg/ml creatine kinase, 0.1l of RNase inhibitor, 10mMdithio-
threitol, 0.5 g DI-72 RNA transcript, and affinity-purified 0.5 g
MBP-36 (CIRV p36) andMBP-p95 (CIRV p95). The volume of the reac-
tion mixture was then adjusted by adding 16 l buffer B (containing 30
mMHEPES-KOH [pH 7.4], 150 mM potassium acetate, and 5 mMmag-
nesium acetate) with 15 mM creatine phosphate, 1 mM ATP, CTP, and
GTP, 0.025 mM UTP, 0.2 l of [32P]UTP, 0.1 mg/ml creatine kinase, 0.2
l of RNase inhibitor, 10mMdithiothreitol, and 0.05mg/ml actinomycin
D. The reaction mixture was incubated at 25°C for 3 h and terminated by
adding 100 l stop buffer (1% sodium dodecyl sulfate and 0.05 M EDTA
[pH 8.0]) followed by 100 l phenol-chloroform extraction and isopro-
panol-ammonium acetate precipitation overnight at20°C and washing
by 70% ethanol. The newly synthesized 32P-labeled RNA products were
incubated at 85°C for 5 min and separated by electrophoresis in a 5%
polyacrylamide gel containing 0.5 Tris-borate-EDTA buffer with 8 M
urea. Signals were detected using a Typhoon 9400 imaging scanner (GE/
Amersham) and quantified by ImageQuant software.
Copurification of host proteins with Twin-Strep-tagged CIRV rep-
lication proteins from yeast. To purify the protein of interest, 200 mg of
BY4741 yeast cells were transformed with plasmids pESC-StrepC36/DI72
pYES-StrepC95 and pRS315-Sti. Cultured yeasts were resuspended and
homogenized in buffer B (50 mM Tris-HCl [pH 7.5], 15 mM MgCl2, 10
mM KCl, 10 mM -mercaptoethanol, 1% [vol/vol] yeast protease inhib-
itor cocktail) by glass beads (modified from reference 28). Membrane
fractions from cell homogenates were collected and solubilized with col-
umn buffer (50 mMTris-HCl [pH 7.5], 15 mMMgCl2, 500 mMKCl, 1%
Triton X-100, 5% caprylyl sulfobetaine [SB3-10; Sigma], 10 mM -mer-
captoethanol, 1% [vol/vol] yeast protease inhibitor cocktail), and incu-
bated with 40 l Strep-Tactin Superflow high-capacity 50% resin (IBA
Life Sciences) for 1 h at 4°C in a column. Strep-Tactin resin was then
washed two timeswith columnbuffer, two timeswithwash buffer (50mM
Tris-HCl [pH 7.5], 15 mM MgCl2, 10 mM KCl, 0.1% Triton X-100, 10
mM -mercaptoethanol, 1% [vol/vol] yeast protease inhibitor cocktail),
and eluted with SDS-PAGE loading buffer and then subjected to SDS-
PAGE and Western blotting with Strep-Tactin AP conjugate (IBA Life
Sciences) and anti-Flag and anti-Hsp70 antibodies (Abcam).
Confocal laser microscopy. Wild-type (wt) BY4741 or sti1 yeast
strains were transformed with the following expression plasmids: pESC-
GFP-C36/DI72, pYES-C95, or pESC-GFP-C33/DI72, pYES-C92 (57), as
well as pRS315-RFP-Sti1p. The yeast cultures were incubated in galactose
medium overnight, sampled, and imaged with an Olympus FV1000 con-
focal laser scanning microscope (Olympus America Inc., Melville, NY).
The microscope settings were the following: excitation and emission for
green fluorescent protein (GFP) and red fluorescent protein (RFP) were
488-nm laser/500- to 530-nm filter and 543-nm laser/560- to 660-nm
filter, respectively.
Virus induced gene silencing of STI1/HOP ortholog gene. Virus-
induced gene silencing (VIGS) in Nicotiana benthamiana was performed
as described in reference 98. The C-terminal fragment of the N. bentha-
miana HOP gene (yeast STI1 ortholog, based on the Arabidopsis
AtHOP-1 gene) was PCR amplified from total N. benthamiana cDNA
using primer pair 5786 (CGCGGATCCAGGGCATACAGCAACAGGGC)/
5787 (CCGCTCGAGTTATTTGACTTGAATAATTCCTGCACTAACCA
AC). The obtained PCR product was digested with BamHI/XhoI and in-
serted into pTRV2 digested with BamHI/XhoI, generating pTRV2-Nb-
Hop. As a control for the VIGS experiments, the C-terminal half of the
GFP sequence was PCR amplified by primer pair 5353 (CGCGGATCCG
AAGGTGATACCCTTGTTAATAGAATCGAG)/3712 (CGGCCTC
GAGTTACGCATAGTCAGGAACATCGTATGGGTAGAGTCCG
GACTTGTATAGTT) from pESC-GFP-C36/DI72, digested with BamHI/
XhoI, and inserted into pTRV2, generating pTRV2–1/2GFP. VIGS-
treated N. benthamiana plants were sap inoculated with CIRV or CNV
inocula on the 14th day postsilencing. Samples from the inoculated leaves
were harvested and subjected to total RNA extraction and Northern blot
analysis for viral RNA (64, 98). Efficiency ofNbHOP silencing was evalu-
ated by semiquantitative reverse transcription-PCR using NbHOP and
Actin gene-specific primer pairs: 5785 (CGCGGATCCAGAGCAGCAAG
AGTATTTCGATCCAC)/5787 and 3993 (GGAAGTAGCATAAGATGG
CAGATGGAGAGG)/3994 (CCAGATCTTCTCCATATCATCCCAGTT
GCTGAC), respectively.
RESULTS
Yeast-based studies reveal that Sti1p cochaperone selectively in-
hibits mitochondrial CIRV replication but not the peroxisomal
TBSV replication. Based on our previous findings that two abun-
dant cytosolic TPR-containing cellular proteins, namely, Cpr7p
cyclophilin and Cns1p cochaperone, showed robust restriction
activity against TBSV (41, 42), we also tested the abundant TPR-
containing protein Sti1p cochaperone for possible effects on the
accumulation of TBSV and CIRV replicon RNAs (repRNAs) in
sti1 yeast versus wt yeast cells. Interestingly, sti1 yeast sup-
ported CIRV repRNA accumulation at an 	3-fold higher level
than that for wt yeast (Fig. 1A, lanes 5 and 6 versus lanes 1 and 2).
However, replication of the TBSV repRNA was comparable in
sti1 and wt yeast (Fig. 1B, lanes 4 to 6 versus lanes 1 to 3), sug-
gesting that Sti1p has a CIRV-specific inhibitory effect. To test if
Sti1p-based inhibition targets theCIRVRNA,we also testedTBSV
repRNA accumulation in the presence of CIRV p36 and p95pol
replication proteins, which are capable of supporting the replica-
tion of the heterologous TBSV repRNA (57), in sti1 yeast versus
wt yeast cells. The obtained data showed an 	2-fold increased
level of TBSV repRNA accumulation (Fig. 1C, lanes 4 to 6 versus
lanes 1 to 3), demonstrating that the inhibitory effect of Sti1p is
targeted against CIRV p36 and p95pol and not the viral RNA.
Comparison of the accumulation of CIRV p36 and p95pol in sti1
yeast versus wt yeast cells revealed similar replication protein lev-
els (Fig. 1C), arguing that Sti1p is unlikely to affect translation or
stability of CIRV p36 and p95pol in yeast cells.
To further test if Sti1p can inhibit CIRV replication in vivo, we
overexpressed N-terminally FLAG-tagged Sti1p in yeast support-
ing CIRV or TBSV accumulation. We found that overexpression
of Sti1p reduced CIRV accumulation up to 	3-fold in wt yeast
(Fig. 2A, lanes 4 to 6 versus lanes 1 to 3) and	5-fold in sti1 yeast
(Fig. 2A, lanes 10 to 12 versus lanes 7 to 9). The level of CIRV p36
and p95pol replication proteins was comparable in sti1 and wt
yeasts overexpressing FLAG-Sti1p (Fig. 2A), suggesting that Sti1p
is unlikely to affect the stability of these viral proteins in yeast. In
contrast, replication of the TBSV repRNA was not affected by the
overexpression of Sti1p in wt (Fig. 2B, lanes 13 to 16) or sti1
(lanes 17 to 24) yeasts. Altogether, these data support the idea that
Sti1p is a strong inhibitor of the CIRV p36 and p95pol replication
proteins, while Sti1p seems to be ineffective against the tombus-
viral p33 and p92pol replication proteins in yeast.
The binding of Sti1p involves different regions in CIRV p36
and the TBSVp33 replication proteins. Sti1p contains three TPR
domains (Fig. 3A) that are predicted to interact with the tombus-
viral replication proteins. To test if Sti1p can interact with the
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CIRV p36 versus the TBSV p33 replication proteins, we first used
the split-ubiquitin-based two-hybrid assay with sti1 yeast (99,
100). We observed a strong interaction between Sti1p and p36
(Fig. 3B) and Sti1p and p33 (Fig. 3C). We confirmed the interac-
tion between Sti1p and p36 replication protein in sti1 yeast (Fig.
3D, lane 2) using a copurification assay with recombinant Sti1p.
The reciprocal copurification assay with Strep-tagged p36 also re-
sulted in copurification of Flag-Sti1p from sti1 yeast (Fig. 3E,
lane 1).
To test what region(s) of Sti1p interacts with p36, we used
well-characterized Sti1pmutants lacking particular functional do-
mains (94, 95) as shown in Fig. 3A. The split-ubiquitin assay
showed that the interaction with p36 was not eliminated by dele-
tion (TPR1) or mutation (C49Y and K73E) in the TPR1 region
(Fig. 3B), which binds to Hsp70 (89, 101). Similarly, deletion
(TPR2) or mutation (G325D or T526I) in the TPR2 region (Fig.
3B), which binds to Hsp90, did not debilitate interaction with p36
replication protein. These findings were confirmed in the recipro-
FIG 1 Increased CIRV replication in sti1 yeast. (A) Northern blot analysis of accumulation of CIRV DI-1 repRNA in sti1 or wt yeast strains at 23°C. We
launched CIRV repRNA replication by expressing CIRV His6-p36 and His6-p95 from the galactose-inducible GAL1 promoter and DI-1 ()repRNA from the
galactose-inducible GAL10 promoter in sti1 and the parental (wt; BY4741) yeast strains. We also overproduced the FLAG-tagged Sti1p in wt yeast to test its
inhibitory function. Note that the data were normalized based on 18S rRNA. Each experiment was repeated three times. (B) Northern blot analysis of
accumulation of TBSVDI-72 repRNA in sti1 or wt yeast strains. TBSV repRNA replicationwas launched by expressing CNVHis6-p33 andCNVHis6-p92 from
theGAL1 promoter andDI-72 ()repRNA from theGAL10 promoter in sti1 and the parental (wt; BY4741) yeast strains. See further details in panel A. Bottom
images, Western blot analysis of CNV His6-p33, CNV His6-p92 accumulation by anti-His antibody, and Sti1p accumulation by anti-Sti1 antibody. (C) Top
images, Northern blot analysis of the CIRV p36/p95-driven TBSV DI-72 RNA accumulation in sti1 or wt yeast strains. Same as panel A except DI-72 was used
as a repRNA with CIRV His6-p36 and His6-p95, which support viral RNA replication on mitochondrial membrane surfaces. Bottom images, Western blot
analysis of CIRV His6-p36, CIRV His6-p95 accumulation by anti-His antibody, and Sti1p accumulation by anti-Sti1 antibody. Each experiment was repeated
three times.
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cal copurification experiments (Fig. 3D and E), demonstrating
that Sti1p could use both the TPR1 andTPR2 sequences to bind to
the p36 replication protein. Interestingly, binding of Sti1p to the
TBSV p33 replication protein showed features similar to those of
p36 binding (Fig. 3C versus Fig. 3B). Thus, the binding character-
istics of Sti1p to CIRV p36 versus TBSV p33 do not explain why
Stip1 can selectively inhibit CIRV replication, but not TBSV rep-
lication, in yeast cells.
To map the Sti1p-binding site in the CIRV p36 replication
protein, we have used pulldown experiments with immobilized
MBP-p36 truncation derivatives (Fig. 4A) and Sti1p present in
either E. coli lysate (Fig. 4B) or yeast extract containing Flag-Sti1p
(Fig. 4C). These experiments revealed that Sti1p binds to a region
that includes the arginine- and proline-rich (RPR) motif of p36,
which is involved in RNA binding (Fig. 4B and C, lanes 6; Fig. 4A,
construct p36C4; and Fig. 4D, construct p36RPR). The RPR
motif in replication proteins is required for specific viral ()RNA
recruitment and replicase assembly, and it also binds to Cpr7p
Cyp40-like cyclophilin (41, 102–104). Interestingly, the same
RPR-containing region in p36 replication protein could bind
to both the TPR1 and TPR2 sequences in Sti1p (Fig. 4E and F,
lanes 6).
To map the Sti1p-binding site in the TBSV p33 replication
protein, we have used similar pulldown experiments with immo-
bilized MBP-p33 truncation derivatives (Fig. 4G) in combination
with yeast extract containing Flag-Sti1p or its truncation deriva-
tives (Fig. 4H). We found that Sti1p binds to the C-terminal re-
gion of TBSV p33 containing the p33-p33/p92 interaction se-
quences (Fig. 4G). Deletion of the RPRmotif, which is involved in
RNA binding, did not inhibit p33 binding to Sti1p (Fig. 4H, lane
13). Thus, there is amajor difference in Sti1p binding toCIRV (the
RPR-containing sequence) and TBSV replication proteins (the
C-terminal region in TBSV p33), suggesting that the mechanism
of inhibition of CIRV replication by Sti1p could be based on
blocking the RNA-binding function of CIRV p36 replication pro-
tein.
Sti1p is colocalized with CIRV p36 in yeast cells. To study if
the mostly cytosolic Sti1p is recruited to the mitochondrial mem-
branes, where CIRV replication takes place (49, 57), by the CIRV
p36, we coexpressed GFP-p36 with RFP-Sti1p in wt or sti1 yeast
cells. Confocal laser microscopy revealed the robust recruitment
of RFP-Sti1p byCIRVp36 to punctate structures, representing the
mitochondrialmembranes as shown before (48, 49, 57) in bothwt
and sti1 yeast cells (Fig. 5A). In contrast, the GFP-tagged p33 did
not efficiently recruit RFP-Sti1p to p33-containing punctate
structures (Fig. 5B), which represent peroxisomal membranes
FIG 2 Overexpression of Sti1p inhibits CIRV accumulation in yeast. (A) Top panel, Northern blot analysis of CIRV RNA accumulation in wt or sti1 yeasts
overproducing the FLAG-tagged Sti1p. Second panel, Northern blot analysis to demonstrate the comparable level of rRNA loading in the yeast samples. Bottom
panels, Western blot analysis of CIRV His6-p95 and CIRV His6-p36 accumulation by anti-His antibody and Sti1p accumulation by anti-Sti1 antibody. (B)
Northern blot analysis of TBSV DI-72 repRNA accumulation in wt or sti1 yeasts overproducing the FLAG-tagged Sti1p in the presence of peroxisomal CNV
p33/p92 replication proteins. Each experiment was repeated three times. See further details in legend to panel A.
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(55, 105). RFP-Sti1p showed a diffused, mostly cytosolic distribu-
tion in yeast expressing p33 replication protein or in the absence
of viral proteins (Fig. 5C). Based on these data, we suggest that
unlike p33, the CIRV p36 replication protein efficiently recruits
Sti1p to the site of replication, leading to robust inhibition of
CIRV replication.
The TPR1 domain in Sti1p is required to inhibit CIRV repli-
cation in isolatedmitochondrion-based assay and in yeast cells.
To test what domain of Sti1p is required to block CIRV replica-
tion, we expressed mutated versions of Sti1p in wt yeast. We ob-
served a 	2-fold inhibition of CIRV repRNA accumulation by
TPR2 and G325Dmutants, comparable to that obtained with the
full-length Sti1p (Fig. 6A), while expression of TPR1 or C49Y
mutants had no detectable and lesser inhibitory effects, respec-
tively (lanes 9 to 12 and 21 to 24 in Fig. 6A). All these mutated
versions of Sti1p were expressed at comparable levels in wt yeast
without substantially affectingCIRVp36 or p95 levels (Fig. 6B and
C). Altogether, based on these data, we suggest that the TPR1
domain of Sti1p is required to inhibit CIRV replication in yeast.
To further test the roles of the TPR sequences of Sti1p in CIRV
replication, we applied an isolated mitochondrion-based replica-
tion assay, which takes advantage of purified recombinant CIRV
p36, p95pol replication proteins, and repRNA transcripts to sup-
port full CIRV replication in vitro (Fig. 7A) (57, 58, 104). Addition
of the affinity-purified full-length recombinant GST-Sti1p (Fig.
7B) decreased the production of repRNA up to 3-fold (Fig. 7C,
lanes 5 to 7 versus lanes 2 to 4), confirming that Sti1p has an
inhibitory effect on CIRV replication in vitro. Preincubation of
FIG 3 Interaction between Sti1p and CIRV p36 replication protein in yeast and in vitro. (A) Domain structure of the yeast Sti1p. Tetratricopeptide repeat 1
(TPR1) sequence interacts with Hsp70, while dipeptide repeat of aspartic acid and proline 1 (DP1) might stabilize the bound client protein. TPR2A and TPR2B
bind toHsp90 and together inhibit the ATPase activity of Hsp90. TPR2B also binds toHsp70, but only in concert withHsp90 binding to TPR2A. The debilitating
mutations are marked with an asterisk, and deletion constructs are shown schematically at the bottom of the panel. (B) A split-ubiquitin MYTH assay was used
to test intracellular interaction between CIRV p36 and the wt ormutated yeast Sti1p. The bait p36 was coexpressed with the prey Sti1p protein in sti1 yeast. The
SSA1 gene (Hsp70 chaperone) and the empty prey vector (NubG)were used as positive and negative controls, respectively. (C) Same split-ubiquitinMYTHassay
as that shown in panel B, except that TBSVp33was used as a bait protein. (D)Copurification of CIRVp36 replication proteinwith the yeast Sti1p from yeast cells.
The membrane fraction of yeast coexpressing the wt or mutated FLAG-Sti1p and His6-p36 was solubilized, and the Sti1p variants were purified using a FLAG
column. The eluted proteins were tested using Western blotting with anti-FLAG antibody (top image) and anti-His6 antibody (bottom image). (E) Reciprocal
copurification of the yeast Sti1p with CIRV p36 and p95 replication proteins from yeast cells. Details are as described for panel D, except yeast coexpressed the
Twin-Strep-tagged CIRV p36 and p95 and Flag-Sti1p. The purification was based on Strep-Tactin columns. The eluted proteins were tested using Western
blotting with anti-Strep-Tactin-AP conjugate (top image), anti-Flag antibody (middle image), and anti-Hsp70 antibody (bottom image). Note that the coopted
Hsp70 is a permanent member of the tombusvirus replicase complex. Each experiment was repeated three times.
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Sti1p either with Ssa1p Hsp70 chaperone or p36 replication pro-
tein to facilitate protein complex formation did not alter the in-
hibitory effect of Sti1p (Fig. 7D), suggesting that Sti1p has a robust
effect on CIRV replication in vitro. The presence of recombinant
Sti1p lacking a functional TPR2 domain (e.g., TPR2 or mutant
G325D) was also inhibitory, reducing CIRV replication up to	5-
fold in the isolated mitochondrion-based assay (Fig. 7C, lanes 11
to 16, and 7D, lanes 15 to 22). In contrast, inactivation of TPR1
(TPR1 or mutant C49Y) resulted in the loss of the inhibitory
function of Sti1p (Fig. 7C, lanes 8 to 10 and 17 to 19, and 7D, lanes
11 to 14) in the isolated mitochondrion-based replication assay,
thus emphasizing the critical role of the TPR1 sequence in Sti1p.
Comparison of the inhibitory effects of host proteins carry-
ing TPR domains on CIRV replication in isolatedmitochondri-
on-based replication assay.Two other cellular proteins with TPR
domains, namely, Cpr7p cyclophilin and Cns1p cochaperone,
have been shown to inhibit TBSV replication (41, 42). To test if
these host proteins have activities comparable to those of Sti1p in
the inhibition ofCIRV replication,we used the isolatedmitochon-
drion-based in vitro replication assay and purified recombinant
cellular proteins and CIRV replication proteins (Fig. 8A and B).
Interestingly, all these TPR-containing proteins inhibited CIRV
replication in vitrowith Sti1p and the TPR region of Cpr7p, show-
ing up to an 	10-fold reduction in repRNA production in the
isolated mitochondrion-based replication assay (Fig. 8A, lanes 6
to 8 and 12 to 14 versus lanes 3 to 5). Cns1p was the least effective
in this assay (Fig. 8A, lanes 15 to 17), but this could be due to the
smaller amount of recombinant GST-Cns1p obtained from E. coli
(Fig. 8B). However, the purified recombinant GST-Cns1p was the
most effective inhibitor of TBSV replication, reducing TBSV rep-
lication up to	20-fold in a cell-free extract (CFE)-based replica-
tion assay (Fig. 8C) (42). Altogether, the TPR-containing Cpr7p
seems to have a strong inhibitory effect against both TBSV and
CIRV replication, while Sti1p efficiently inhibits CIRV, but its
effect on TBSV replication in vitro is only moderate.
The plantHop ortholog of the yeast Sti1p inhibits CIRV rep-
lication in yeast and plants. Arabidopsis thaliana has three or-
thologs of Sti1p cochaperone, namely, AtHop1-3, that carry TPR1
and TPR2 domains (96, 106). AtHop-1 has 558 amino acids that
show 40% identity and 57% similarity with ScSti1, which is 589
amino acids long.Using themembrane yeast two-hybrid (MYTH)
assay, we showed a strong interaction between CIRV p36 replica-
tion protein and the AtHop-1 ortholog (Fig. 9A). These data con-
firmed the pulldown experiments with recombinant AtHop-1 and
CIRVp36 that also showed the involvement of the RPR domain in
p36 in the interaction with AtHop-1 (Fig. 4D).
To test if AtHop-1 could inhibit CIRV replication, we ex-
pressed it in yeast. Similar to results with the yeast Sti1p, AtHop-1
inhibited CIRV accumulation	5-fold in yeast (Fig. 9B, lanes 4 to
6). Deletion of the TPR1 sequence made AtHop-1 less effective
FIG 4 Defining the sequence within the tombusvirus replication proteins needed for binding to Sti1p in vitro. (A) Schematic representation of the CIRV p36 and
its truncated derivatives used in the binding assay. The various domains include the transmembrane domain (TMD), the arginine- and proline-rich (RPR)
RNA-binding domain, the phosphorylated serine and threonine (P) domain, and the S1 and S2 subdomains involved in p36-p36/p95 interaction. (B to F)
Affinity binding (pulldown) assay to detect interaction between Flag- orHis6-Sti1p,TPR1,TPR2, AtHop1, and theMBP-taggedCIRVp36 protein derivatives.
The MBP-tagged viral proteins produced in E. coli were immobilized on amylose affinity columns. The recombinant Sti1p and derivatives expressed in E. coli
(panels B, D, E, and F) or in yeast (panel C) were then passed through the amylose affinity columns with immobilized MBP-tagged p36 protein (its truncated
versions). The affinity-bound proteins were eluted withmaltose from the columns (shown in the bottom image). Top images in each panel, eluted proteins were
analyzed byWestern blotting with anti-Flag or anti-His antibodies to detect the amount of Flag- or His6-Sti1p specifically bound to MBP-tagged viral proteins.
Bottom images, SDS-PAGE analysis of the viral protein and its truncated derivatives after elution from the amylose affinity columns. Note that the MBP has a
C-terminal extra tail sequence (not present in the fusion protein constructs) due to the sequence in the original cloning vector. (G) Schematic representation of
the TBSV p33 and its truncated derivatives used in the binding assay. (H) Affinity binding (pulldown) assay to detect interaction between FLAG-Sti1p and the
MBP-tagged viral p33 protein (the soluble C-terminal portion). TheMBP-tagged viral protein or MBP control produced in E. coliwas immobilized on amylose
affinity columns. See further details in legend to panel B. The eluted proteins were analyzed byWestern blotting with anti-FLAG antibody to detect the amount
of FLAG-Sti1p specifically bound to MBP-tagged viral protein.
FIG 5 Relocalization of yeast Sti1p cochaperone when coexpressed with CIRV p36 replication protein in yeast. (A) Confocal laser microscopy images show the
partial colocalization of RFP-Sti1 with CIRV GFP-p36 in wt (BY4741; top two panels), or in sti1 (bottom panels) yeast strains. The merged images show the
colocalizationwithin punctate structures, representingmitochondria, which are the sites of CIRV replication. Differential interference contrast (DIC) images are
shown on the right. (B) Absence of colocalization of RFP-Sti1 and GFP-p33 in yeast. Note the cytosolic distribution of RFP-Sti1, while GFP-p33 is present in
punctate structures representing the peroxisomes. (C) Mostly cytosolic distribution of RFP-Sti1p in the absence of viral proteins in BY4741 yeast. Each
experiment was repeated.
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inhibitor of CIRV replication (Fig. 9B, lanes 7 to 9), suggesting
that the TPR1 sequence is important for the inhibitory function of
AtHop-1.
To test the relevance of the plant Hop protein in tombusvirus
replication, we tested the accumulation level of Hop mRNA in
the Nicotiana benthamiana host. The semiquantitative reverse
transcription-PCR (RT-PCR) analysis revealed the induction of
NbHopmRNA upon infection with CIRV (Fig. 10A). In addition,
knockdown of NbHop level via VIGS in N. benthamiana led to
	3-fold-increased CIRV genomic RNA accumulation (Fig. 10B).
As expected, due to the high level of CIRV accumulation, the
Hop-knockdown N. benthamiana plants developed more severe
symptoms than control plants when infected with CIRV (Fig.
10C). In contrast, the accumulation of the genomic RNA of the
related CNV (a peroxisomal replicating tombusvirus, closely re-
lated to TBSV) was not significantly affected by Hop-knockdown
N. benthamiana plants (Fig. 10D). Also, the symptom severity of
CNV-infected knockdown or control plants was comparable (Fig.
10E). Based on these in planta experiments, we suggest that the
plant Hop ortholog plays a potent inhibitory role, similar to that
of the yeast Sti1p, in the mitochondrial CIRV replication, but not
in the peroxisomal CNV replication.
DISCUSSION
Identification of theHop-like Sti1p cochaperone as a novel cell-
intrinsic restriction factor against CIRV replication in mito-
chondria. Cellular protein chaperones are important for virus
replication and during other steps of the infectious process (10,
107–113). For example, Hsp70 has been shown to affect the intra-
cellular localization and membrane insertion of TBSV replication
proteins and the assembly of the tombusviral VRCs (62, 63, 104).
Although Hsp70 interacts directly with the tombusviral replica-
tion proteins, it is possible that other cellular factors could affect
the subversion of Hsp70s by TBSV. Since cochaperones facilitate
selection and delivery of client proteins to the major Hsp70 and
Hsp90 chaperones (114–116), some cochaperones might also be
involved in viral infections, as demonstrated in this paper and
earlier (10, 107–113).
Our finding that the conserved cellular Hop-like Sti1p cochap-
erone is a restriction factor for CIRV replication in the mitochon-
dria contributes to the emerging complex roles of cellular chaper-
ones in virus replication (10).While deletion of Sti1p led to a 2- to
4-fold increase in CIRV replication in the yeast model host, and
knockdown of the orthologous Hop inN. benthamiana increased
CIRV accumulation	3-fold, overexpression of Sti1p or AtHop-1
in yeast was inhibitory. In vitro CIRV replication experiments
based on isolated mitochondria also confirmed the robust inhib-
itory effect of Sti1p on CIRV.Moreover, the expression of the Sti1
orthologHop is increased duringCIRV replication in plant leaves.
Thus, Sti1p is a newmember of the growing family of cell-intrinsic
restriction factors.
However, Sti1p did not have a robust effect on replication of
the closely related TBSV in yeast or on the replication of CNV in
plants, both of which utilize the peroxisomal membranes for rep-
lication (55, 105). This contrasting finding with different tombus-
viruses exploiting different subcellular locations could be due to
the difference in accessibility of Sti1/Hop to replication proteins of
tombusviruses in their respective cellular environments. For ex-
ample, it has been shown in plants that Hop/Sti1 is involved in
transportation of freshly synthesized mitochondrial and chloro-
plast proteins from the cytosol into these organelles (117). More-
over, the delivery/import of mitochondrial preproteins from the
cytosol to the mitochondria often depends on Hsp70/Hsp90
chaperones and includesHop/Sti1 and the TPRdomain in Tom70
FIG 6 Functional TPR1 domain of Sti1p is required for inhibition of CIRV replication in yeast. (A) Northern blot analysis of CIRV accumulation in wt yeast
overproducing the FLAG-tagged Sti1p or derivatives. Bottom panel, Northern blot analysis to demonstrate the comparable level of rRNA loading in the yeast
samples. (B)Western blot analysis of CIRVHis6-p36, and CIRVHis6-p95 accumulation by anti-His antibody from yeast overproducing Sti1p or derivatives. (C)
Detection of the overproduced FLAG-Sti1p or its derivatives in yeast byWestern blotting using anti-FLAG antibody. Each experiment was repeated three times.
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mitochondrial receptor (118, 119). Also, the CIRVp36 replication
proteinwas shown to interactwith various Tomreceptor proteins,
which might have roles in mitochondrial membrane insertion of
p36 (47). Based on these studies, we propose that Sti1/Hop might
be easily accessible and bind efficiently to the mitochondrion-
targeted CIRV replication proteins in cells, while the cellular Sti1/
Hop cochaperone has a lesser chance to bind to the peroxisome-
targeted TBSV and CNV replication proteins. Accordingly, live-
cell imaging showed the relocalization of Sti1p to the
mitochondria in the presence of CIRV p36, while Sti1p showed
mostly cytosolic localization in yeast cells expressing the CNV p33
replication protein (Fig. 5). Thus, the difference in accessibility of
Sti1/Hop could be themajormechanism restricting CIRV but not
TBSV or CNV replication.
Mechanisms of Sti1p cochaperone-driven restriction of
CIRV replication. Recruitment of the tombusvirus ()RNA into
replication requires selective binding by the tombusvirus replica-
tion proteins via recognition of a RNA recruitment element
(named p33RE) within the polymerase gene sequence (54, 120).
The same p33RE element is also required for the VRC assembly
FIG 7 Functional TPR1 domain of Sti1p blocks CIRV replication in vitro. (A) Scheme of in vitro reconstitution of the CIRV replicase in yeast mitochondrial
preparation. The purified GST-tagged Sti1p or derivatives, the purified recombinant CIRVMBP-p36 andMBP-p95 proteins and the TBSV-derived ()repRNA
were used in isolated mitochondrial preparations. (B) Coomassie blue-stained SDS-PAGE was used for analysis of affinity-purified GST-tagged Sti1 or deriva-
tives. MW, molecular weight (noted on y axis; in thousands). (C) Denaturing PAGE analysis of the 32P-labeled repRNA products obtained in the replication
assays with the isolated yeast mitochondrial preparation and the soluble fraction of yeast CFE that provided soluble host factors. The arrowhead indicates
synthesized full-length repRNA. The replication assay with CIRV p36 and p95 (without added Sti1) was chosen as 100% (lane 1). The recombinant proteins were
added in 8, 16, and 32 M amounts. Each experiment was repeated. (D) CIRV mitochondrial replication assays were performed (see panel A) to test the effect
of preincubation of various components. Lanes “a” show samples for which the purified Ssa1p Hsp70 (from the sti1 yeast strain) was preincubated for 10 min
with a comparable amount ofGST,GST-Sti1p, ormutants (fromE. coli), while in lanes “b,” theMBP-p36/MBP-p95 ofCIRV (fromE. coli)was preincubatedwith
Ssa1p. In lanes “c,” the MBP-p36/MBP-p95 of CIRV was preincubated with GST, GST-Sti1p, or mutants, while in lanes “-,” no preincubation was performed.
In each experiment, we used comparable amounts of each component for preincubation that lasted for 10min in the reaction buffer. After the preincubation step,
we added the missing components and performed the CIRV replication assay (see panel A). Each experiment was repeated at least twice.
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and activation of the polymerase function of the replication pro-
tein (102, 121). The specific recognition of p33RE is performed by
arginines within the RPR motif in p33/p92pol (122, 123). There-
fore, binding of cellular factors to the RPR motif-containing re-
gion could block the ability of tombusvirus replication proteins to
bind the viral ()RNA, thus inhibiting the essential viral pro-
cesses of ()RNA recruitment, VRC assembly, and replicase acti-
vation (121, 124). Indeed, the TPR domain of Cpr7p binds to the
RPR region in the tombusvirus p33/p92pol replication proteins
and blocks the above viral processes, thus acting as a restriction
factor (41). We find that Sti1p also binds to the RPR region in the
CIRV p36/p95pol replication proteins (Fig. 4), and this could ex-
plain the strong in vitro inhibitory effect of recombinant Sti1p on
CIRV replication based on mitochondrial preparations (Fig. 7).
The CIRV p36 interaction with Sti1p also leads to the recruitment
of Sti1p to punctate structures (mitochondrial membranes) in
yeast cells, suggesting robust p36-Sti1p interaction in cells. Thus,
direct interaction between the Sti1p and CIRV p36 might block
viral RNA recruitment (Fig. 11, Model 1).
However, the picture on the mechanism of CIRV inhibition is
likely more complex. This is because both the TPR1 and TPR2
regions of Sti1p bind to the RPR domain of CIRV p36/p95pol, yet
the expression of TPR1 is inhibitory, while TPR2 is less effective in
reducing CIRV accumulation in yeast or CIRV replication in vitro
withmitochondrial preparations (Fig. 6 and 7). Thus, the binding
to the RPR domain in p36/p95pol is unlikely enough for Sti1p to
effectively inhibit p36 or p95pol functions.
Interestingly, Sti1p does not bind to the RPR region of the
TBSV p33 replication protein. The binding between p33 and Sti1p
involves the C-terminal region of p33 containing the p33-p33/p92
interaction sequence (Fig. 4G to H) and likely the corresponding
sequence in p92pol. It is possible that this interaction is not robust
or stable enough to interfere with p33/p92pol functions in cells. It
is likely that p33 could readily interact with additional p33 mole-
cules, while binding to Sti1p molecules by p33 might be less fa-
FIG 9 Inhibition of CIRV replication by expression of the orthologous
AtHop-1 in yeast. (A) A Split-ubiquitinMYTH assay was used to test intracel-
lular interaction between CIRV p36 and the AtHop-1 ortholog of the yeast
Sti1p. The bait p36 was coexpressed with the prey AtHop-1 protein in yeast.
The SSA1 gene and the empty prey vector (NubG) were used as positive and
negative controls, respectively. (B) Northern blot analysis of CIRV RNA accu-
mulation in wt yeast overproducing the FLAG-tagged AtHop-1 or its TPR1-
deletion derivative. Second panel, Northern blot analysis to demonstrate the
comparable level of rRNA loading in the yeast samples. Third and fourth
panels, Western blot analysis of CIRV His6-p36 and CIRV His6-p95 accumu-
lation by anti-His antibody. Bottom panels, detection of the overproduced
FLAG-AtHop-1 in yeast by Western blotting using anti-FLAG antibody and
the Coomassie blue-stained SDS-PAGE as a loading control. Each experiment
was repeated three times.
FIG 8 Comparison of the inhibitory effects of TPR-containing cellular proteins on CIRV replication in isolated mitochondria in vitro. (A) Denaturing PAGE
analysis of the 32P-labeled repRNAproducts obtained in the replication assayswith the isolated yeastmitochondrial preparations. The purifiedGST-tagged Sti1p,
the yeast Cpr7p Cyp40-like cyclophilin, or the TPR domain of Cpr7p or Cns1p cochaperone (8, 16, and 32 M) was added in combination with purified
recombinant CIRV MBP-p36 and MBP-p95 proteins and the TBSV-derived ()repRNA to the isolated mitochondrial preparations to perform the in vitro
replication assay. The synthesized full-length repRNA is marked by an arrow. See further details in the legend to Fig. 7. (B) Coomassie blue-stained SDS-PAGE
was used for analysis of affinity-purified GST-tagged Sti1p, Cpr7p, and Cns1p. (C) The level of in vitro TBSV repRNA replication in total yeast cell extracts in the
presence of purified TBSV p33 and p92 replication proteins and purified GST-tagged Sti1p, Cpr7p, the TPR domain of Cpr7p or Cns1p (16 and 32 M). Each
experiment was repeated three times.
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vored in cells. Indeed, Sti1p is not efficiently relocalized to punc-
tate structures containing the p33 molecules in yeast cells (Fig.
5B). A similar situation was observed with Cpr6p Cyp40-like cy-
clophilin, which also binds to p33 within the C-terminal domain
and does not inhibit p33 functions (41). Yet this rule is not gen-
eral, since Cns1p cochaperone binds to the p33-p33/p92 interac-
tion sequence in TBSV p33 replication protein and effectively in-
hibits TBSV replication in yeast (42) and in vitro (Fig. 8C). It
seems that the intracellular distribution/accessibility of these
TPR-containing host proteins might be a major factor in their
ability to inhibit replication of different tombusviruses.
Although direct interaction between the RPR region of CIRV
p36 and the TPR1 sequence in Sti1p might explain the inhibitory
effect on CIRV replication (Fig. 11, Model 1), it is also possible
that Sti1p limits the functions of subverted cellular factors, such as
Hsp70, for its antiviral activity. Cytosolic Hsp70s are coopted by
tombusviruses, and they are permanent residents in the tombus-
viral VRCs (39). This model is supported by the observation that,
in spite of the binding of both TPR1 and TPR2 sequences to the
RPR region of CIRV p36 (Fig. 3), only the expression of the
Hsp70-interacting TPR1 region (89, 91) was able to robustly in-
hibit CIRV replication in yeast and in vitro (Fig. 6 and 7). More-
FIG 10 Knockdown of Hop gene by VIGS increases CIRV accumulation in whole plants. (A) Semiquantitative RT-PCR analysis of the accumulation ofNbHOP
mRNAs in CIRV-infectedN. benthamiana plants 3 days postinoculation (dpi) and in the control mock-inoculated plants. Semiquantitative RT-PCR analysis of
theNbActinmRNA level served as a control. (B) Top image, accumulation of CIRV genomic and subgenomic RNAs in the inoculated leaves ofHOP-knockdown
N. benthamiana plants at 2 dpi, based on Northern blot analysis. VIGS was performed via agroinfiltration of TRV vectors carryingNbHOP sequence or the TRV
vector carrying the C-terminal half of a GFP insert (as a control). Inoculation with CIRV gRNA was done 14 days after VIGS. Second image, rRNA level in the
samples used as loading control. Bottom images, Semiquantitative RT-PCR analysis of the accumulation ofNbHOPmRNA in the knockdownN. benthamiana
plants and in the control plants 2 days after inoculation with CIRV. Semiquantitative RT-PCR analysis of the NbActin mRNA from the same samples served as
a control. (C) Development of more severe CIRV-induced symptoms in the NbHOP-knockdown plant (shown on the right) at 7 dpi than those in the control
plant infiltrated with the control TRV vector. Note the minor phenotypic effect in the uninfected NbHOP-knockdown N. benthamiana plants for the control
plants (left), which were agroinfiltrated with the pTRV1/2GFP vector. (D) Accumulation of CNV gRNA in the inoculated leaves of HOP-knockdown N.
benthamiana plants 2 days postinoculation, based on Northern blot analysis. See further details in panel B. Note that the peroxisome-localized CNV and TBSV
replication proteins behave similarly in yeast cells (not shown) in regard to lack of effect by the Sti1p onCNVorTBSV replication. (E)Comparable CNV-induced
symptom development in the HOP-knockdown and control plants. See further details in panel C. Each experiment was repeated three times.
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over, mutation within the TPR1 sequence (i.e., mutant C49Y) that
debilitates the interaction with Hsp70, but not with p36 (Fig. 3)
had lesser inhibitory effects on CIRV replication when expressed
in yeast (Fig. 6). In contrast, a mutation (i.e., G325D) that affects
interaction with Hsp90 did not interfere with the inhibitory func-
tion of Sti1p in vivo or in vitro. Based on these findings, we propose
that the recruited Sti1p cochaperone inhibits the proviral function
of the coopted cellular Hsp70molecules during CIRV replication.
For example, the predicted Sti1p-Hsp70 interaction during the
formation of VRC or within the assembled VRCmight inhibit the
Hsp70-driven activation of the polymerase function of p95pol or
other steps/functions (Fig. 11, Model 2).
Themajor role of the Sti1p cochaperone in eukaryotic cells is to
bring the Hsp70-client protein complex together with the Hsp90
chaperone to facilitate robust refolding/activation of client pro-
teins by the powerful Hsp90 system (91, 125, 126). This is facili-
tated by the ability of Sti1p to bind simultaneously to Hsp70 (via
the TPR1 sequence) andHsp90 (via the TPR2A region). However,
based on our data, it is unlikely that this function of Sti1p is critical
to inhibit CIRV replication. This is because deletion of the entire
TPR2 domain from Sti1p did not eliminate the inhibitory func-
tion of Sti1p in vitro or in yeast (Fig. 6 and 7). Also, blocking the
function of Hsp90 by applying a geldanamycin inhibitor in yeast
had no effect on tombusvirus replication (data not shown), argu-
ing against the functional role of Hsp90 in tombusvirus replica-
tion. Therefore, the direct effect of Sti1p on CIRV p36/p95pol and
the coopted Hsp70 is the best suited to explain the current exper-
imental data (Fig. 11).
Sti1/Hop is the first cellular restriction factor specifically affect-
ing one tombusvirus (i.e., CIRV, which replicates in the mito-
chondria) but not other tombusviruses (TBSV and CNV, which
both replicate in peroxisomal membranes). The previously iden-
tified TPR domain-containing cellular proteins, namely, Cpr7p
andCns1p, could inhibit the replication of all these tombusviruses
(this work and references 41 and 42). Interestingly, all three cellu-
lar factors are part of the Hsp70/Hsp90 chaperone system, sug-
gesting that they, at least in part, inhibit tombusvirus replication
via regulating chaperone functions. Because the Hsp70/Hsp90
chaperone system is known to affect many viruses (reviewed in
references 10 and 127), it is possible that the identified restriction
factor activities of these TPR-containing cellular proteins might
be functional against other viruses and pathogens.
Another use of Hop/Sti1 in host innate defense against patho-
gens is its role in the maturation and transport of rice chitin re-
ceptor OsCERK1, which is a pattern recognition receptor (PRR),
against rice blast fungus (128). This function of Hop/Sti1 might
link the functions of PRRs, small Rho-type GTPases, and resis-
tance against pathogens. Sti1p is also known to affect prion prop-
agation in yeast (129), and its expression is increased in simian
virus 40 (SV40)-transformedMRC-5 fibroblasts and some tumor
tissues (79, 130). Thus, Hop/Sti1 is emerging as a possibly key
component in propagations of several infectious agents and in-
nate defense responses of host cells.
Summary. The current and recent works (41, 42) with tom-
busviruses indicate that somemembers of the large family of TPR-
containing proteinsmight act as cell-intrinsic restriction factors of
tombusviruses. The list includes the Hop-like Sti1p and Ttc4 on-
cogene-like Cns1p cochaperones and Cyp40-like Cpr7p cyclophi-
lin. Yet, based on the yeast Cyp40-like Cpr6p cyclophilin (41), we
already know that not all TPR-containing proteins are viral re-
striction factors in spite of their abilities to interact with tombus-
virus replication proteins. Since many TPR-containing proteins
are expressed in all eukaryotes, it will be important to identify all
the members of this cellular protein family that act as restriction
factors during the replication of tombusvirus and other ()RNA
viruses.
FIG 11 Models on the inhibitory role of Sti1p cochaperone in CIRV replication. Model 1 predicts that direct interaction between Sti1p and the RPR region of
CIRV p36 replication protein blocks the viral ()RNA recruitment function of p36, and thus blocks replication of CIRV.Model 2 emphasizes the additional role
of Sti1p through the coopted Hsp70 chaperone. Binding of the TPR1 domain of Sti1p to Hsp70 within the CIRV replicase might inhibit the function of the
subverted Hsp70 in VRC assembly, by possibly stabilizing the Hsp70-p95pol complex. Note that both mechanisms might operate inside the cell.
Xu et al.
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